Information Technology · Services-Computer Programming Services

CTSH Cognizant SEC Filings & Insider Trading Activity 2026

company
CIK 1058290203 filings
Nasdaq 100
S&P 500

CTSH at a glance

Cognizant (CTSH, SEC CIK 1058290) filed its latest 10-K annual report on February 12, 2026, a 10-Q quarterly report on October 29, 2026, an 8-K current report on October 29, 2026 and Form 4 insider filings as recently as November 10, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Cognizant (CTSH) reported revenue of $21.1 billion (up 7.0% from FY2024) and net income of $2.2 billion. Diluted EPS was $4.56.
  • As of September 30, 2026, 38 institutional investment managers tracked by SignalX reported holding Cognizant (CTSH) shares worth $11.5 billion in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Kerdman Alina on September 30, 2026 of 139 shares at $56.88 per share.
  • In the last 90 days, CTSH insiders reported 0 open-market purchases ($0) and 4 open-market sales ($184K) on Form 4, a net sale of $184K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$21.1B
+7.0% vs prior year
Insiders · 90 days
0 buys · 4 sells
Net −$184K
13F holders
38 funds
$11.5B · −1 vs prior quarter
Latest 8-K
Oct 29, 2026
Item 7.01 · Item 2.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business model: Technology-driven digital transformation services with focus on AI, data, and customer-centric solutions
  • New emphasis on AI and GenAI integration in client offerings and internal operations
  • Strategic focus on supporting clients' productivity, cost savings, and resilience amid geopolitical and regulatory uncertainties
  • Potential impact on effective tax rate from March 2024 India-Mauritius Income Tax Treaty amendment involving key subsidiaries
  • Recognition of evolving AI market competitiveness and risk of reduced demand/pricing pressure for existing services

Risk Factors

  • One-time $390M non-cash income tax expense from enactment of OBBBA impacting 2025 effective tax rate
  • 23% of global operating costs in India exposed to Indian rupee exchange rate fluctuations, affecting operating margin by ~50 basis points in 2025
  • Dilutive impact on Products and Resources segment margin from integration and third-party resales post Belcan acquisition
  • Increased competition risk from technology shifts affecting Communications Media and Technology segment customers
  • $1.85B unsecured revolving credit facility available, with $300M repayment in 2025 and $650M Term Loan due October 2027

Management Discussion & Analysis

  • Revenue $20,986M, up $1,372M or 7.0% YoY; 6.4% growth in constant currency; Belcan acquisition added 260 bps
  • Operating margin 16.1% vs 14.7% YoY; Adjusted operating margin 15.8% vs 15.3%, driven by NextGen savings and FX benefits
  • Health Sciences and Financial Services best performers; Products & Resources and Communications Media & Technology faced weakness
  • Cash tax savings $200M from U.S. tax law change; $390M non-cash tax expense reduced GAAP EPS by $0.80, adjusted EPS up 11.2%
  • Voluntary tech attrition down to 13.9% from 15.9%; Headcount increased to 351,600 from 336,800 at year-end 2024

AI summary of the CTSH 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • Project Leap disruption: Headcount reductions may cause loss of institutional knowledge and impair client-service delivery
  • Project Leap costs: Expected total charges of $180 million to $250 million
  • Cost-savings execution: Unforeseen delays or costs could prevent anticipated operational efficiencies
  • Workforce retention: Restructuring may hinder recruitment and retention of remaining employees

Management Discussion & Analysis

  • Q3 revenue $5,664M, up $249M or 4.6% YoY, 4.8% constant currency
  • GAAP operating margin 15.4% vs 16.0%; adjusted margin 16.3% vs 16.0%
  • Best segment Financial Services, revenue up 12.0%; worst Health Sciences, revenue down 1.1%
  • Operating cash flow $1,836M YTD vs $2,025M; cash and short-term investments $1,552M
  • Project Leap costs revised to $180M-$250M; AI investment, tariffs, macro uncertainty and communications-media weakness as headwinds

AI summary of the CTSH 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Oct 29, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Investor presentation covers quarter ended September 30, 2026
  • Exhibit 99.3 contains additional financial information for investor review

Item EX-99.2: Item EX-99.2

  • Q3 2026 revenue $5.7B, up 4.6% reported and 4.8% constant currency, above guidance midpoint
  • GAAP operating margin 15.4%, adjusted operating margin 16.3%, marking seventh consecutive quarter of adjusted margin expansion

Item EX-99.3: Item EX-99.3

  • Q3 revenue $5,664M, up 4.6% YoY, with acquisitions contributing approximately 210 basis points
  • Adjusted diluted EPS $1.49 versus $1.39, while GAAP EPS $1.39 reflects comparison against a prior-year $0.80 tax charge

Item EX-99.1: Item EX-99.1

  • Q3 revenue $5.7B, up 4.6% year over year, with Financial Services growing 12%
  • Adjusted operating margin 16.3%, up 30 basis points, while GAAP margin fell 60 basis points to 15.4%

Item 2.02: Results of Operations and Financial Condition

  • Cognizant reported financial results for the quarter ended September 30, 2026
  • Press release and accompanying infographic filed as Exhibits 99.1 and 99.2 for detailed results
Filed Oct 6, 2026Full analysis →

Item 1.01: Entry into a Material Definitive Agreement

  • New unsecured facilities: $550 million term loan plus $1.85 billion revolving capacity
  • Approximately $1.0 billion revolver draw used primarily to refinance existing revolving debt

Item 2.03: Creation of a Direct Financial Obligation

  • Item 2.03 links the financial obligation to the material agreement described under Item 1.01
  • Investors should review Item 1.01 for borrowing amount, terms, maturity, interest rate and intended use of funds
Filed Jul 29, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Investor presentation covers quarter ended June 30, 2026
  • Exhibit 99.3 contains additional financial information for investor review

Item EX-99.1: Item EX-99.1

  • Q2 revenue $5.481B, up 4.5% YoY; Financial Services delivered 12% growth, reinforcing AI-led demand in its largest segment
  • Adjusted operating margin 16.0%, up 40 basis points; adjusted EPS $1.37, up 4.6%, showing operating leverage despite moderate growth

Item 2.02: Results of Operations and Financial Condition

  • Cognizant reported financial results for the quarter ended June 30, 2026
  • Full earnings release and accompanying infographic available in Exhibits 99.1 and 99.2

Item EX-99.16: Item EX-99.16

  • Q2 revenue $5.481B, up 4.5% YoY, with Financial Services growth reaching 12%
  • Adjusted operating margin 16.0%, up 40 basis points, while GAAP margin reached 15.9%

Item EX-99.36: Item EX-99.36

  • Q2 revenue $5.481B, up 4.5% year-over-year, with constant-currency growth of 4.1%
  • GAAP operating margin 15.9% and adjusted margin 16.0%, expanding 30 and 40 basis points respectively

AI summaries of CTSH 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for CTSH

Don't miss the next CTSH filing

  • Alerts as it files. A push when CTSH files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut CTSH, by share count.
  • Ask anything. An AI agent that reads every CTSH filing and answers with sources.

CTSH alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Kerdman AlinaANov 7, 2026-
Kerdman AlinaMOct 1, 2026-
Kerdman AlinaFOct 1, 2026$57.44
Kerdman AlinaMOct 1, 2026-
Kerdman AlinaSellSep 30, 2026$56.88
Dalal Jatin PMSep 15, 2026-
Dalal Jatin PMSep 15, 2026-
Dalal Jatin PFSep 15, 2026$64.10

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$19.7B$21.1B
Operating Income-$2.9B$3.4B
Net Income$2.1B$2.2B$2.2B
Op. Margin-14.7%16.1%
Net Margin-11.3%10.6%
Balance Sheet
Total Assets$18.5B$20.0B$20.7B
Equity-$14.4B$15.0B
ROE-15.5%14.9%
Per Share
EPS$4.21$4.51$4.56
Cash Flow
Operating CF-$2.1B$2.9B
CapEx$317.0M$297.0M$288.0M

Source: XBRL data in Cognizant (CTSH)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate CTSH share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
CTSH shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202638$11.52B
Q2 202639$8.59B
Q1 202639$14.50B
Q4 202538$19.26B
Q3 202542$17.05B
Q2 202539$18.14B
Q1 202537$13.73B
Q4 202433$10.80B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
None this quarter.
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 305 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

CTSH filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 10, 2026--
10-QOct 29, 2026Analysis
8-KOct 29, 2026Analysis-
8-KOct 6, 2026Analysis-
4Oct 5, 2026--
4Oct 2, 2026--
4Sep 17, 2026--
4Sep 17, 2026--
4Sep 17, 2026--
4Sep 17, 2026--
4Sep 17, 2026--
4Sep 17, 2026--
4Sep 17, 2026--
4Sep 17, 2026--
4Sep 16, 2026--
4Sep 4, 2026--
4Sep 3, 2026--
4Sep 3, 2026--
4Sep 3, 2026--
4Sep 3, 2026--
4Sep 3, 2026--
4Sep 3, 2026--
4Sep 3, 2026--
4Sep 3, 2026--
4Sep 2, 2026--

Related Information Technology companies

All Information Technology →

CTSH SEC filings: frequently asked questions

Are CTSH insiders buying or selling?

In the last 90 days, Cognizant (CTSH) officers, directors and 10% owners reported no open-market purchases and 4 open-market sales worth $183,820 by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold CTSH stock?

As of September 30, 2026, the largest Cognizant (CTSH) holders among the 13F filers tracked by SignalX were BlackRock ($2.5 billion), Vanguard Capital Management LLC ($1.7 billion), Vanguard Portfolio Management LLC ($1.4 billion), State Street Corp ($1.3 billion), Invesco Ltd ($839.9 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was CTSH's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Cognizant (CTSH) reported revenue of $21.1 billion (up 7.0% from FY2024) and net income of $2.2 billion. Diluted EPS was $4.56. The figures come from the XBRL data in the 10-K.

What are the main risks in CTSH's latest 10-K?

In the 10-K filed February 12, 2026, Cognizant (CTSH) flagged: One-time $390M non-cash income tax expense from enactment of OBBBA impacting 2025 effective tax rate. 23% of global operating costs in India exposed to Indian rupee exchange rate fluctuations, affecting operating margin by ~50 basis points in 2025. (AI summary of the Risk Factors section.)

What did CTSH report in its latest 8-K?

Cognizant (CTSH) filed an 8-K on October 29, 2026 reporting Item 7.01 (Regulation FD Disclosure) and Item 2.02 (Results of Operations and Financial Condition). Investor presentation covers quarter ended September 30, 2026.

What are the latest CTSH SEC filings?

Cognizant (CTSH) filed its latest 10-K annual report on February 12, 2026, a 10-Q quarterly report on October 29, 2026, an 8-K current report on October 29, 2026 and a Form 4 insider filing on November 10, 2026.

What is CTSH's SEC CIK number?

Cognizant (CTSH)'s SEC Central Index Key (CIK) is 1058290. EDGAR lists every CTSH filing under that number.

Ask anything about CTSH

The research agent reads CTSH's filings, financials, insider trades and 13F holders, then answers with sources.